Hyeog June is a Project Manager and Specialist(especially MES) at DONG-A ST. In this company, he is responsible for everything from the OT to IT system of the ISA 95 model. As a project engineer, he has experience in building GMP OT/IT system in brownfield. As a project manager, he has experience in building GMP OT/IT system in green field(e.g. MES, WMS, SCADA). Prior to DONG-A ST, Hyeog June was in charge of production technology engineer at LG Chemistry and a data center's embedded system engineer at NAVER CLOUD.

Skilled in System Process Design&Development, Interface and Integration Management between systems(IT-IT, OT-IT, OT-OT), Network Infra & Cloud Management, GMP OT/IT system management(e.g. Security, CSV, Audit trail, Privilege and Back-up&Recovery). Also engineering all of these. Working as the only system administrator at the unit factory.

In 2022, Dong-A ST achieved notable financial results, with sales reaching KRW 635.8 billion, a 7.7% YoY increase, and operating profit soaring 97% to KRW 30.5 billion. This success was attributed to balanced growth across all business units, driven by increased sales and licensing-out fees. The ETC business experienced a 4.5% YoY growth in domestic sales, fueled by key items like Growtropin. Overseas sales surged by 10%, benefiting from eased blockades post-COVID-19 and favorable exchange rates. In the medical equipment sector (excluding diagnostics), Dong-A ST achieved a remarkable 20.3% YoY growth, expanding its product line. Investing over 13% of sales in R&D annually, Dong-A ST prioritizes key therapeutic areas—oncology, inflammatory disease, neurodegenerative diseases, endocrine system, digestive system, and musculoskeletal system. Notably, the completion of a phase III global clinical trial for DMB-3115 (Stelara biosimilar) in November 2022 showcased therapeutic equivalence and safety, with a U.S. and European drug approval application underway as of April 2023. In 2022, Dong-A ST reinforced its commitment to environmental and safety standards. The Cheonan/Daegu Campus passed ISO 14001 and ISO 45001 audits, while also obtaining ISO 50001 certification for energy management. The Cheonan Campus solar power plant commenced full operation, complemented by eco-friendly practices like substituting box packaging tape with paper tape. Dong-A ST received top ratings (Overall A from KCGS, Overall AA from Sustinvest) in external ESG evaluations, solidifying its position in the Korean pharmaceutical industry.